The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Nick Bansback

Health Economics and Decision Science

ScHARR (School of Health and Related Research)

University of Sheffield

Sheffield

UK

[email]@sheffield.ac.uk

Name/email consistency: high

 
 
 
 
 
 
 

Affiliation

  • Health Economics and Decision Science, ScHARR (School of Health and Related Research), University of Sheffield, Sheffield, UK. 2004 - 2007

References

  1. Using contrast sensitivity to estimate the cost-effectiveness of verteporfin in patients with predominantly classic age-related macular degeneration. Bansback, N., Davis, S., Brazier, J. Eye. (Lond) (2007) [Pubmed]
  2. Determinants of health related quality of life and health state utility in patients with age related macular degeneration: the association of contrast sensitivity and visual acuity. Bansback, N., Czoski-Murray, C., Carlton, J., Lewis, G., Hughes, L., Espallargues, M., Brand, C., Brazier, J. Qual. Life. Res (2007) [Pubmed]
  3. Estimating the cost and health status consequences of treatment with TNF antagonists in patients with psoriatic arthritis. Bansback, N.J., Ara, R., Barkham, N., Brennan, A., Fraser, A.D., Conway, P., Reynolds, A., Emery, P. Rheumatology. (Oxford) (2006) [Pubmed]
  4. Cost effectiveness of adalimumab in the treatment of patients with moderate to severe rheumatoid arthritis in Sweden. Bansback, N.J., Brennan, A., Ghatnekar, O. Ann. Rheum. Dis. (2005) [Pubmed]
  5. Economic evaluation of gemcitabine in the treatment of pancreatic cancer in the UK. How important is quality of life?. Bansback, N., Ward, S., Karnon, J. Eur. J. Health. Econ (2004) [Pubmed]
 
WikiGenes - Universities